Chris Comrack
Specialist Leader, Federal Health Strategy
Deloitte Consulting, LLP

Mr. Chris Comrack is a Specialist Leader in Deloitte’s Federal Health Strategy Practice with a focus on Digital Health regulatory transformation in the Federal Government and Life Sciences Healthcare sectors to enable strategic change. Chris brings over 17 years of Life Sciences industry and academic research experience, in addition to over 9 years in Federal Health Strategy consulting.

Chris’ work at Deloitte has focused on supporting large scale regulatory transformation projects around Digital Health, Compounded Drugs, Drug Labeling and IT system implementations at the US Food and Drug Administration (FDA) to address new public health challenges and meet Congressional mandates. Prior to Deloitte, Chris worked in a number of R&D, business development, and technology licensing roles at Vanda Pharmaceuticals, Ore Pharmaceuticals, Millennium Pharmaceuticals, Beth Israel Deaconess Medical Center and Massachusetts General Hospital.